1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
Foster, A.; Resnikoff, S. The impact of Vision 2020 on global blindness. Eye 2005, 19, 1133–1135. [CrossRef]
Iwase, A.; Araie, M.; Tomidokoro, A.; Yamamoto, T.; Shimizu, H.; Kitazawa, Y. Prevalence and causes of low
vision and blindness in a Japanese adult population: The Tajimi Study. Ophthalmology 2006, 113, 1354–1362.
[CrossRef] [PubMed]
Weinreb, R.N.; Khaw, P.T. Primary open-angle glaucoma. Lancet 2004, 363, 1711–1720. [CrossRef]
Alvarado, J.A.; Murphy, C.G. Outflow obstruction in pigmentary and primary open angle glaucoma.
Arch. Ophthalmol. 1992, 110, 1769–1778.
Lütjen-Drecoll, E.; Shimizu, T.; Rohrbach, M.; Rohen, J.W. Quantitative analysis of “plaque material” in the innerand outer wall of Schlemm’s canal in normal- and glaucomatous eyes. Exp. Eye Res. 1986, 42, 443–455. [CrossRef]
Izzotti, A.; Bagnis, A.; Saccà, S.C. The role of oxidative stress in glaucoma. Mutat. Res. 2006, 612, 105–114.
[CrossRef]
Izzotti, A.; Longobardi, M.; Cartiglia, C.; Saccà, S.C. Mitochondrial damage in the trabecular meshwork occurs
only in primary open-angle glaucoma and in pseudoexfoliative glaucoma. PLoS ONE 2011, 6, e14567. [CrossRef]
Takai, Y.; Tanito, M.; Ohira, A. Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle
glaucoma, exfoliation glaucoma, and cataract. Invest. Ophthalmol. Vis. Sci. 2012, 53, 241–247. [PubMed]
Tanito, M.; Kaidzu, S.; Takai, Y.; Ohira, A. Status of systemic oxidative stresses in patients with primary
open-angle glaucoma and pseudoexfoliation syndrome. PLoS ONE 2012, 7, e49680. [CrossRef] [PubMed]
Umeno, A.; Tanito, M.; Kaidzu, S.; Takai, Y.; Horie, M.; Yoshida, Y. Comprehensive measurements of
hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma
patients and controls. Sci. Rep. 2019, 9, 2171. [CrossRef] [PubMed]
Umeno, A.; Tanito, M.; Kaidzu, S.; Takai, Y.; Yoshida, Y. Involvement of free radical-mediated oxidation
in the pathogenesis of pseudoexfoliation syndrome detected based on specific hydroxylinoleate isomers.
Free Radic. Biol. Med. 2020, 147, 61–68. [CrossRef] [PubMed]
Tanito, M.; Kaidzu, S.; Takai, Y.; Ohira, A. Correlation between Systemic Oxidative Stress and Intraocular
Pressure Level. PLoS ONE 2015, 10, e0133582. [CrossRef] [PubMed]
Tanito, M.; Kaidzu, S.; Takai, Y.; Ohira, A. Association between systemic oxidative stress and visual field
damage in open-angle glaucoma. Sci. Rep. 2016, 6, 25792. [CrossRef] [PubMed]
Yamada, E.; Himori, N.; Kunikata, H.; Omodaka, K.; Ogawa, H.; Ichinose, M.; Nakazawa, T. The relationship
between increased oxidative stress and visual field defect progression in glaucoma patients with sleep
apnoea syndrome. Acta Ophthalmol. 2018, 96, e479–e484. [CrossRef]
Manabe, K.; Kaidzu, S.; Tsutsui, A.; Mochiji, M.; Matsuoka, Y.; Takagi, Y.; Miyamoto, E.; Tanito, M. Effects of
French maritime pine bark/bilberry fruit extracts on intraocular pressure for primary open-angle glaucoma.
J. Clin. Biol. Chem.. (in print). [CrossRef]
Monnier, V.M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J. Gerontol. 1990,
45, B105–B111. [CrossRef]
Tessier, F.J. The Maillard reaction in the human body. The main discoveries and factors that affect glycation.
Pathol. Biol. 2010, 58, 214–219. [CrossRef]
Verzijl, N.; DeGroot, J.; Thorpe, S.R.; Bank, R.A.; Shaw, J.N.; Lyons, T.J.; Bijlsma, J.W.; Lafeber, F.P.;
Baynes, J.W.; TeKoppele, J.M. Effect of collagen turnover on the accumulation of advanced glycation end
products. J. Biol. Chem. 2000, 275, 39027–39031. [CrossRef]
Meerwaldt, R.; Graaff, R.; Oomen, P.H.N.; Links, T.P.; Jager, J.J.; Alderson, N.L.; Thorpe, S.R.; Baynes, J.W.;
Gans, R.O.B.; Smit, A.J. Simple non-invasive assessment of advanced glycation endproduct accumulation.
Diabetologia 2004, 47, 1324–1330. [CrossRef]
Sugisawa, E.; Miura, J.; Iwamoto, Y.; Uchigata, Y. Skin autofluorescence reflects integration of past long-term
glycemic control in patients with type 1 diabetes. Diabetes Care 2013, 36, 2339–2345. [CrossRef]
Antioxidants 2020, 9, 755
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
9 of 11
Schweitzer, C.; Cougnard-Gregoire, A.; Rigalleau, V.; Dartigues, J.F.; Malet, F.; Rougier, M.B.; Delyfer, M.N.;
Helmer, C.; Korobelnik, J.F.; Delcourt, C. Autofluorescence of Skin Advanced Glycation End Products as a
Risk Factor for Open Angle Glaucoma: The ALIENOR Study. Invest. Ophthalmol. Vis. Sci. 2018, 59, 75–84.
[CrossRef] [PubMed]
Beisswenger, P.J.; Makita, Z.; Curphey, T.J.; Moore, L.L.; Jean, S.; Brinck-Johnsen, T.; Bucala, R.; Vlassara, H.
Formation of immunochemical advanced glycosylation end products precedes and correlates with early
manifestations of renal and retinal disease in diabetes. Diabetes 1995, 44, 824–829. [CrossRef] [PubMed]
Kilhovd, B.K.; Juutilainen, A.; Lehto, S.; Rönnemaa, T.; Torjesen, P.A.; Hanssen, K.F.; Laakso, M. Increased
serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in
women with type 2 diabetes: A population-based 18 year follow-up study. Diabetologia 2007, 50, 1409–1417.
[CrossRef] [PubMed]
Noordzij, M.J.; Mulder, D.J.; Oomen, P.H.; Brouwer, T.; Jager, J.; Castro Cabezas, M.; Lefrandt, J.D.; Smit, A.J.
Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes
mellitus-a multi-centre study. Diabet. Med. 2012, 29, 1556–1561. [CrossRef]
Meerwaldt, R.; Links, T.P.; Graaff, R.; Hoogenberg, K.; Lefrandt, J.D.; Baynes, J.W.; Gans, R.O.; Smit, A.J.
Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical
manifestation of diabetic neuropathy. Diabetologia 2005, 48, 1637–1644. [CrossRef]
Tabara, Y.; Ikezoe, T.; Yamanaka, M.; Setoh, K.; Segawa, H.; Kawaguchi, T.; Kosugi, S.; Nakayama, T.;
Ichihashi, N.; Tsuboyama, T.; et al. Advanced Glycation End Product Accumulation Is Associated With Low
Skeletal Muscle Mass, Weak Muscle Strength, and Reduced Bone Density: The Nagahama Study. J. Gerontol.
A Biol. Sci. Med. Sci. 2019, 74, 1446–1453. [CrossRef]
Tabara, Y.; Yamanaka, M.; Setoh, K.; Segawa, H.; Kawaguchi, T.; Kosugi, S.; Nakayama, T.; Matsuda, F.
Advanced Glycation End Product Accumulation is Associated with Lower Cognitive Performance in an
Older General Population: The Nagahama Study. J. Alzheimers Dis. 2020, 74, 741–746. [CrossRef]
Nowotny, K.; Jung, T.; Grune, T.; Höhn, A. Accumulation of modified proteins and aggregate formation in
aging. Exp. Gerontol. 2014, 57, 122–131. [CrossRef]
Dyer, D.G.; Dunn, J.A.; Thorpe, S.R.; Bailie, K.E.; Lyons, T.J.; McCance, D.R.; Baynes, J.W. Accumulation
of Maillard reaction products in skin collagen in diabetes and aging. J. Clin. Invest. 1993, 91, 2463–2469.
[CrossRef]
Li, J.; Liu, D.; Sun, L.; Lu, Y.; Zhang, Z. Advanced glycation end products and neurodegenerative diseases:
Mechanisms and perspective. J. Neurol. Sci. 2012, 317, 1–5. [CrossRef]
Kandarakis, S.A.; Piperi, C.; Topouzis, F.; Papavassiliou, A.G. Emerging role of advanced glycation-end
products (AGEs) in the pathobiology of eye diseases. Prog. Retin. Eye Res. 2014, 42, 85–102. [CrossRef]
[PubMed]
Satish Kumar, M.; Mrudula, T.; Mitra, N.; Bhanuprakash Reddy, G. Enhanced degradation and decreased
stability of eye lens alpha-crystallin upon methylglyoxal modification. Exp. Eye Res. 2004, 79, 577–583.
[CrossRef] [PubMed]
Ishibashi, T.; Murata, T.; Hangai, M.; Nagai, R.; Horiuchi, S.; Lopez, P.F.; Hinton, D.R.; Ryan, S.J. Advanced
glycation end products in age-related macular degeneration. Arch. Ophthalmol. 1998, 116, 1629–1632.
[CrossRef] [PubMed]
Tezel, G. Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences. Prog. Retin.
Eye Res. 2006, 25, 490–513. [CrossRef]
Hondur, G.; Göktas, E.; Yang, X.; Al-Aswad, L.; Auran, J.D.; Blumberg, D.M.; Cioffi, G.A.; Liebmann, J.M.;
Suh, L.H.; Trief, D.; et al. Oxidative Stress-Related Molecular Biomarker Candidates for Glaucoma.
Investig. Ophthalmol. Vis. Sci. 2017, 58, 4078–4088. [CrossRef]
Amano, S.; Kaji, Y.; Oshika, T.; Oka, T.; Machinami, R.; Nagai, R.; Horiuchi, S. Advanced glycation end
products in human optic nerve head. Br. J. Ophthalmol. 2001, 85, 52–55. [CrossRef]
Tezel, G.; Luo, C.; Yang, X. Accelerated aging in glaucoma: Immunohistochemical assessment of advanced
glycation end products in the human retina and optic nerve head. Invest. Ophthalmol. Vis. Sci. 2007, 48,
1201–1211. [CrossRef]
Bentata, R.; Cougnard-Grégoire, A.; Delyfer, M.N.; Delcourt, C.; Blanco, L.; Pupier, E.; Rougier, M.B.;
Rajaobelina, K.; Hugo, M.; Korobelnik, J.F.; et al. Skin autofluorescence, renal insufficiency and retinopathy
in patients with type 2 diabetes. J. Diabetes Complicat. 2017, 31, 619–623. [CrossRef]
Antioxidants 2020, 9, 755
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
10 of 11
Yasuda, M.; Shimura, M.; Kunikata, H.; Kanazawa, H.; Yasuda, K.; Tanaka, Y.; Konno, H.; Takahashi, M.;
Kokubun, T.; Maruyama, K.; et al. Relationship of skin autofluorescence to severity of retinopathy in type 2
diabetes. Curr. Eye Res. 2015, 40, 338–345. [CrossRef]
Gerrits, E.G.; Lutgers, H.L.; Kleefstra, N.; Graaff, R.; Groenier, K.H.; Smit, A.J.; Gans, R.O.; Bilo, H.J.
Skin autofluorescence: A tool to identify type 2 diabetic patients at risk for developing microvascular
complications. Diabetes Care 2008, 31, 517–521. [CrossRef]
Yamanaka, M.; Matsumura, T.; Ohno, R.; Fujiwara, Y.; Shinagawa, M.; Sugawa, H.; Hatano, K.; Shirakawa, J.;
Kinoshita, H.; Ito, K.; et al. Non-invasive measurement of skin autofluorescence to evaluate diabetic
complications. J. Clin. Biochem. Nutr. 2016, 58, 135–140. [CrossRef] [PubMed]
McIntyre, N.J.; Fluck, R.J.; McIntyre, C.W.; Taal, M.W. Skin autofluorescence and the association with renal and
cardiovascular risk factors in chronic kidney disease stage 3. Clin. J. Am. Soc. Nephrol. 2011, 6, 2356–2363. [CrossRef]
[PubMed]
Den Hollander, N.C.; Mulder, D.J.; Graaff, R.; Thorpe, S.R.; Baynes, J.W.; Smit, G.P.; Smit, A.J. Advanced
glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia. J. Inherit.
Metab. Dis. 2007, 30, 916–923. [CrossRef] [PubMed]
Ahmad, M.S.; Damanhouri, Z.A.; Kimhofer, T.; Mosli, H.H.; Holmes, E. A new gender-specific model for
skin autofluorescence risk stratification. Sci. Rep. 2015, 5, 10198. [CrossRef]
Noordzij, M.J.; Lefrandt, J.D.; Graaff, R.; Smit, A.J. Dermal factors influencing measurement of skin
autofluorescence. Diabetes Technol. Ther. 2011, 13, 165–170. [CrossRef] [PubMed]
Koetsier, M.; Nur, E.; Chunmao, H.; Lutgers, H.L.; Links, T.P.; Smit, A.J.; Rakhorst, G.; Graaff, R. Skin color
independent assessment of aging using skin autofluorescence. Opt. Express 2010, 18, 14416–14429. [CrossRef]
Yue, X.; Hu, H.; Koetsier, M.; Graaff, R.; Han, C. Reference values for the Chinese population of skin
autofluorescence as a marker of advanced glycation end products accumulated in tissue. Diabet. Med. 2011,
28, 818–823. [CrossRef] [PubMed]
Mulder, D.J.; Water, T.V.; Lutgers, H.L.; Graaff, R.; Gans, R.O.; Zijlstra, F.; Smit, A.J. Skin autofluorescence, a
novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: An overview of
current clinical studies, evidence, and limitations. Diabetes Technol. Ther. 2006, 8, 523–535. [CrossRef]
Li, X.; Dinish, U.S.; Aguirre, J.; Bi, R.; Dev, K.; Attia, A.B.E.; Nitkunanantharajah, S.; Lim, Q.H.; Schwarz, M.;
Yew, Y.W.; et al. Optoacoustic mesoscopy analysis and quantitative estimation of specific imaging metrics in
Fitzpatrick skin phototypes II to V. J. Biophotonics 2019, 12, e201800442. [CrossRef]
Chan, I.L.; Cohen, S.; da Cunha, M.G.; Maluf, L.C. Characteristics and management of Asian skin.
Int. J. Dermatol. 2019, 58, 131–143. [CrossRef]
Himori, N.; Kunikata, H.; Kawasaki, R.; Shiga, Y.; Omodaka, K.; Takahashi, H.; Miyata, T.; Nakazawa, T.
The association between skin autofluorescence and mean deviation in patients with open-angle glaucoma.
Br. J. Ophthalmol. 2017, 101, 233–238. [CrossRef] [PubMed]
Himori, N.; Kunikata, H.; Shiga, Y.; Omodaka, K.; Maruyama, K.; Takahashi, H.; Nakazawa, T. The
association between systemic oxidative stress and ocular blood flow in patients with normal-tension
glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 2016, 254, 333–341. [CrossRef] [PubMed]
Singh, R.; Barden, A.; Mori, T.; Beilin, L. Advanced glycation end-products: A review. Diabetologia 2001, 44,
129–146. [CrossRef] [PubMed]
Dawczynski, J.; Vater, C.; Kasper, M.; Franke, S.; Augsten, R.; Jurkutat, S.; Strobel, J.; Königsdörffer, E.
Advanced glycation end products and pseudoexfoliation—Correlation between clinical outcome and
histological findings. Klin Monbl Augenheilkd 2006, 223, 748–751. [CrossRef] [PubMed]
Zhou, L.; Li, Y.; Yue, B.Y. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells
from an ocular tissue: The trabecular meshwork. J. Cell. Physiol. 1999, 180, 182–189. [CrossRef]
Yoshida, Y.; Umeno, A.; Shichiri, M. Lipid peroxidation biomarkers for evaluating oxidative stress and
assessing antioxidant capacity in vivo. J. Clin. Biochem. Nutr. 2013, 52, 9–16. [CrossRef] [PubMed]
Umeno, A.; Shichiri, M.; Ishida, N.; Hashimoto, Y.; Abe, K.; Kataoka, M.; Yoshino, K.; Hagihara, Y.; Aki, N.;
Funaki, M.; et al. Singlet oxygen induced products of linoleates, 10- and 12-(Z,E)-hydroxyoctadecadienoic
acids (HODE), can be potential biomarkers for early detection of type 2 diabetes. PLoS ONE 2013, 8, e63542.
[CrossRef]
Antioxidants 2020, 9, 755
58.
59.
60.
61.
62.
63.
64.
11 of 11
Thornalley, P.J. Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and
enzymatic detoxification—A role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol. 1996,
27, 565–573. [CrossRef]
Thornalley, P.J.; Westwood, M.; Lo, T.W.; McLellan, A.C. Formation of methylglyoxal-modified proteins
in vitro and in vivo and their involvement in AGE-related processes. Contrib. Nephrol. 1995, 112, 24–31.
[PubMed]
Fu, M.X.; Wells-Knecht, K.J.; Blackledge, J.A.; Lyons, T.J.; Thorpe, S.R.; Baynes, J.W. Glycation, glycoxidation,
and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard
reaction. Diabetes 1994, 43, 676–683. [CrossRef] [PubMed]
Ando, K.; Beppu, M.; Kikugawa, K.; Nagai, R.; Horiuchi, S. Membrane proteins of human erythrocytes are
modified by advanced glycation end products during aging in the circulation. Biochem. Biophys. Res. Commun.
1999, 258, 123–127. [CrossRef] [PubMed]
Fu, M.X.; Requena, J.R.; Jenkins, A.J.; Lyons, T.J.; Baynes, J.W.; Thorpe, S.R. The advanced glycation end
product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions.
J. Biol. Chem. 1996, 271, 9982–9986. [CrossRef] [PubMed]
Nicholl, I.D.; Bucala, R. Advanced glycation endproducts and cigarette smoking. Cell. Mol. Biol. 1998, 44,
1025–1033. [PubMed]
Cerami, C.; Founds, H.; Nicholl, I.; Mitsuhashi, T.; Giordano, D.; Vanpatten, S.; Lee, A.; Al-Abed, Y.;
Vlassara, H.; Bucala, R.; et al. Tobacco smoke is a source of toxic reactive glycation products. Proc. Nat. Acad.
Sci. USA 1997, 94, 13915–13920. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
...
論文の公開元へ
